41 S-Collate COHORT ‘REAL-LIFE’ STUDY: EFFICACY AND SAFETY OF PEGINTERFERON alfa-2a (40KD) IN 1233 PATIENTS WITH CHRONIC HEPATITIS B ACCORDING TO ASIAN AND CAUCASIAN RACE

Table 1 (abstract 41).Efficacy rates 6 months post-treatment according to Asian and Caucasian race and HBeAg status Response variable HBeAg-positive HBeAg-negative at 6 months post-treatment Asian n/N (%) Caucasian n/N (%) p-value Asian n/N (%) Caucasian n/N (%) 41